Kejriwal asks PM to share vaccine formula with pharma firms to ramp up manufacturing
He said the Centre can also terminate the monopoly on vaccine production through the patent law
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COVAXIN
Bharat Biotech begins direct supply of COVAXIN to 14 states
The firm has started supplying its COVID-19 vaccine to the states based on the allocations received by the central government
Tech transfers, collaborations, materials supply key to scale up vaccine manufacturing: Suchitra…
Bharat Biotech is in the process of ramping up the manufacturing capacity of Covaxin to 70 crore dosages per annum
PHDCCI urges GOI to enable voluntary licensing and urgently ramp up manufacture of Covaxin,…
The Government should try to incentivise directly the foreign companies which own the patents for the other COVID-19 vaccines also…
SII endorses receiving Rs 1,732 crore for 11 crore doses of Covishield vaccine
The company's response came after the Health Ministry in a statement refuted the allegations that it has not placed any fresh…
No more the pharmacy/vaccine maker of the world?
India has risen like a phoenix before, but this time, this resilience comes at too high a price
Covaxin prices slashed from Rs 600 to Rs 400 per dose for states
The announcement came one day after the Serum Institute of India, reduced the price of Covishield from ₹400 to ₹300
Efforts to ramp up production of COVID-19 vaccines, easy availability underway: Renu Swarup
The regulators have also permitted manufacturing at risk and stockpiling doses even before approval so that they can be rolled out…
Bharat Biotech, ICMR announce interim results from Phase 3 trials of COVAXIN
It demonstrates overall interim clinical efficacy of 78 per cent and 100 per cent efficacy against severe COVID-19 disease
Bharat Biotech announces COVAXIN capacity expansion
Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for COVAXIN